13F-HR filed by First Light Asset Management, LLC
First Light Asset Management, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:37:04 UTC, with 32 holding rows worth $1,687,217,357.
- Accession
- 0001999371-26-025524
- Filer
- CIK 1600004
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 32 entries on the cover page, a total value of $1,687,217,357 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,687,217,357 with VALUE read as dollars as filed, 13F file number 028-16064. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AXOGEN INC | 05463X106 | COM | 3,737,085 | $156,658,603 | dollars as filed | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 8,459,556 | $155,317,448 | dollars as filed | |
| SI BONE INC | 825704109 | COM | 7,687,346 | $144,522,105 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 3,986,548 | $116,008,547 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 734,086 | $101,252,482 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 2,482,940 | $100,807,364 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 430,348 | $83,160,448 | dollars as filed | |
| 908 DEVICES INC COM | 65443P102 | Stock | 6,641,149 | $81,951,779 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 437,882 | $78,100,634 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 1,960,386 | $63,300,864 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 786,901 | $56,892,942 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 3,983,577 | $54,814,020 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 3,251,835 | $53,037,429 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 1,018,334 | $46,680,431 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 1,164,271 | $45,557,924 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 599,653 | $41,591,932 | dollars as filed | |
| SIMULATIONS PLUS INC | 829214105 | COM | 2,241,165 | $41,304,671 | dollars as filed | |
| ATRICURE INC | 04963C209 | COM | 662,134 | $37,211,931 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 2,387,265 | $34,185,635 | dollars as filed | |
| TRISALUS LIFE SCIENCES INC | 89680M101 | COM | 7,416,274 | $31,964,141 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 214,713 | $24,404,280 | dollars as filed | |
| BUTTERFLY NETWORK INC | 124155102 | COM CL A | 2,613,227 | $23,414,514 | dollars as filed | |
| HEALTH CATALYST INC | 42225T107 | COM | 12,748,770 | $22,055,372 | dollars as filed | |
| BETA BIONICS INC | 08659B102 | COMMON STOCK | 1,109,420 | $21,056,792 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 328,523 | $16,511,566 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 495,950 | $11,550,676 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 237,744 | $10,377,526 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 142,820 | $8,126,458 | dollars as filed | |
| KORU MEDICAL SYSTEMS INC | 759910102 | COMMON STOCK | 2,745,372 | $8,043,940 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 83,467 | $7,947,313 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 99,219 | $6,366,883 | dollars as filed | |
| SPDR Bloomberg 1-3 Month T-Bill ETF | 78468R663 | SHS | 33,181 | $3,040,707 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001999371-26-025524 | this filing | 2026-11-16 |